First Edition: Thursday, June 4, 2026
Today's early morning highlights from the major news organizations.
Archives: Morning Breakouts
801-820 of 113,127 results
-
-
-
Viewpoints: Military’s Extreme Masculinity Might Be Sparking Eating Disorders; California Community Colleges Should Offer Bachelor’s Degrees In Nursing
Opinion writers delve into these topics and others.
By khnlaureno -
California Psychiatric Hospitals Now Must Meet Staffing Requirements, Or Face Steep Fines
Hospitals must assign one nurse for every six patients in adult psychiatric units, and one nurse for every five adolescent patients, the San Francisco Chronicle reported. Hospitals that violate the rule can be fined $15,000 to $30,000 per day. Also: New SNAP work requirements take effect in Washington, D.C.
-
Nursing Associations Sue Department of Education Over Student Loan Limit Rule
The new rule strips the "professional degree" designation from graduate nursing students, a move that caps what they may borrow to $20,500 annually or $100,000 in aggregate, MedPage Today reports. The lawsuit argues that this exclusion is unlawful and violates the Administrative Procedure Act.
-
Primary Election Results Show Tight Race For California Governor, With Healthcare Promises On The Line
Democrat Xavier Becerra, a former U.S. health secretary, and Republican Steve Hilton were neck-and-neck Wednesday morning, but full results could take many days or weeks. In other government news, the U.S. House of Representatives approved a major increase in benefits for some of the nation's most catastrophically disabled veterans, Military.com reported.
-
Trump Admin Wants Sneak Peeks At Developing AI Models That Could Help Guide Health Industry
The government is looking to assess the advanced cyber capabilities of AI models ahead of their full release to the public in an attempt to benchmark the process, CNBC reports. Plus: weight-loss drugs and cancer prevention; genetic therapies for brain disease research; and more.
-
As Ebola Rages, Rubio To Take Reins From RFK Jr. Over Control Of US Relationship With Gavi
According to The New York Times, Secretary of State Marco Rubio has indicated that the United States may resume funding of Gavi, a global vaccines alliance that provides immunizations for low-income nations. Gavi maintains the global Ebola vaccine stockpile. Health Secretary Robert F. Kennedy Jr. has blocked funding for it.
-
New Work Requirement Rule Panned By Medicaid Advocates, Health Industry
Public health experts note the "medical frailty" exemption, and specifically the bureaucratic red tape it will create, will lead to even more people losing their Medicaid coverage. “This is where we’ll see large and harmful coverage losses,” one public health expert told Stat.
-
First Edition: Wednesday, June 3, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
Viewpoints: US Needs Stricter Rules To Prevent The Spread Of Ebola; It’s Too Easy To Get Drunk Or High In America
Opinion writers weigh in on these topics and others.
By khnlaureno -
Texas Children’s Hospital Will Create Nation’s First ‘Detransition Clinic’
The Washington Post reports on a previously unreleased settlement agreement between Texas Attorney General Ken Paxton, a Republican, and the Houston hospital, which is the nation’s largest pediatric hospital. The clinic will provide surgery, fertility counseling, and therapy, among other services. Also: About 374,000 Californians canceled their Covered California marketplace health coverage during the first quarter of the year.
-
Eli Lilly To Hospitals: Give Us Claims Data Or Lose 340B Price Breaks
The message went out to about 50 hospitals, Stat reports, and comes as part of the company's effort to reduce what it calls duplicate discounts paid to participating hospitals. Other industry news is on pediatric prior authorization, telehealth, autism therapy, and more.
-
Florida Launches Lawsuit Against OpenAI, CEO, Alleging They Disregarded Dangers Of ChatGPT
Florida’s lawsuit claims OpenAI and CEO Sam Altman prioritized commercial gain over user safety. Experts both inside and outside the company repeatedly warned about the dangers of the product that facilitates and encourages self-harm and violence, AP wrote.
-
FDA Green-Lights Drug For People 12 And Older Who Are Exposed To Covid
FiercePharma reports on how Shionogi’s oral antiviral drug — sold under the name Xocova and available in Japan since 2022 — has been cleared by the FDA for post-exposure prophylaxis for U.S. adults and some adolescents who have been exposed to covid. This makes it the first post-exposure covid oral drug approved in the United States.
-
As Ebola Outbreak Grows, 3 Vaccine Candidates Are Fast-Tracked
The Bundibugyo strain of the Ebola virus has no targeted vaccine or therapeutics, CIDRAP reports. Experts say that the outbreak, which is already the third-largest in history, is likely much worse than official numbers suggest.
-
CMS Releases Guidelines For Medicaid Work Requirements, Exemptions
The guidance to states indicates pregnant women, parents of young children, veterans with disabilities, and people who are “medically frail” are among the Medicaid enrollees who may be exempt from work requirements, but not people who are homeless, NBC reports. Also: The Trump administration has been blocked from removing currently enlisted transgender service members.
-
First Edition: Tuesday, June 2, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
Viewpoints: We Need Clearer Data On The Doctors Being Cut From Residency; Enhanced Games Weren’t The Spectacle We Expected
Opinion writers weigh in on these topics and others.
By khnlaureno -
Convicted Sex Offender Jeffrey Epstein May Have Used A Sperm Bank, Records Show
Emails and records released by the Justice Department indicate Epstein had been banking his DNA for at least several years, but it's unclear whether it is still being preserved, The New York Times reported. One law expert told The Times that the issue of whether it is ethical for a facility to accept sperm from a sex offender is an ongoing debate in the fertility industry.